Donor Tr1 Cells Potently Expand in vivo and Prevent GVHD after TLI/ATS Non-myeloablative Conditioning and Allogeneic Bone Marrow Transplantation

Journal article

Peer reviewed

Marie van der Merwe, Taren Ong, Peter Vogel, Tracy George and Asha Pillai

Clinical immunology (Orlando, Fla.), Vol.135, pp.S27-S27

2010

Metrics

7 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Donor Tr1 Cells Potently Expand in vivo and Prevent GVHD after TLI/ATS Non-myeloablative Conditioning and Allogeneic Bone Marrow Transplantation
Creators: Marie van der Merwe - St. Jude Children's Research Hospital, Memphis, TN
Taren Ong - St. Jude Children's Research Hospital, Memphis, TN
Peter Vogel - St. Jude Children's Research Hospital, Memphis, TN
Tracy George - Stanford University, Stanford, CA
Asha Pillai - St. Jude Children's Research Hospital, Memphis, TN
Publication Details: Clinical immunology (Orlando, Fla.), Vol.135, pp.S27-S27
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Department of Pediatrics; UMMG Dept of Pediatrics - Hematology/Oncology/Stem Cell Transp
Language: English
Resource Type: Journal article
Record Identifier: 991031600490002976